Company: PSTV
Filing Date: 2025-07-21
Form Type: DEF 14A
Source: 0001140361-25-026611
Chunk: 28

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-21
Form: DEF 14A
Chunk 28
---
 Audit Committee simultaneously serves on the audit committees of more than three (3) public companies, and no member of our Audit Committee has participated in the preparation of the financial statements of Plus at any time during the past three (3) years. The primary purpose of the audit committee is to discharge the responsibilities of our Board with respect to our corporate accounting and financial reporting processes, systems of internal control and financial-statement audits, and to oversee our independent registered accounting firm. Specific responsibilities of our Audit Committee as provided in the Audit Committee Charter include:

| • | reviewing management’s and our independent auditor’s report on their assessment of the effectiveness of internal control over financial reporting as of the end of each fiscal year; |

| • | selecting our auditors and reviewing the scope of the annual audit; |

| • | resolving any disagreements between management and the auditor regarding financial reporting; |

| • | approving the audit fees and non-audit fees to be paid to our auditors; |

| • | reviewing our financial accounting controls with the staff and the auditors; |

| • | reviewing and monitoring management’s enterprise risk management assessment, including cybersecurity; |

| • | reviewing and discussing with management and the auditor, our audited financial statements including our disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; |

| • | reviewing our earnings press releases as well as financial information and earnings guidance provided to analysts and rating agencies; |

| • | reviewing and approving our annual budget; |

| • | reviewing all related person transactions which are required to be reported under applicable SEC regulations; and |

| • | establishing procedures for the receipt, retention, and treatment of complaints received regarding accounting, internal accounting controls or audit matters. |

Compensation Committee Our Compensation Committee currently consists of Mr. Guse and Mr. Clowes, who serves as the committee’s Chairperson. Our Board has determined that both Mr. Guse and Mr. Clowes are independent under Nasdaq listing standards and are “non-employee directors” as defined in Rule 16b-3 promulgated under the Exchange Act. The primary duties and responsibilities of our Compensation Committee as provided in the Compensation Committee Charter include, among other things, overseeing our compensation policies, plans and programs and determine the compensation to be paid to our executive officers, directors and other senior management, as appropriate. Specific responsibilities of our Compensation Committee include:

| • | developing and implementing compensation programs for our executive officers and other employees, subject to the discretion of the full Board; |

|